Partnering to Promote Global Health

Gilead recognizes that the development of world-class medicines for life-threatening diseases is only one aspect of improving public health. We also invest in programs that promote prevention, strengthen healthcare infrastructure, and provide education and social and financial support to the most vulnerable communities around the world.

By enabling access to medicines, challenging assumptions, fighting stigma and collaborating with partners worldwide, we work not simply to treat the world’s most challenging public health threats – but to eradicate them.

Fighting HIV/AIDS in the Southern U.S. – COMPASS

The Gilead COMPASS (COMmitment to Partnership in Addressing HIV/AIDS in Southern States) Initiative is our $100 million, 10-year commitment to help address HIV/AIDS in the South – home to about 44 percent of people living with AIDS in the U.S.

Read More

Gilead and WHO tackle VL in Southeast Asia

Visceral leishmaniasis (VL), a parasitic disease with about 400,000 new cases a year in Southeast Asia, is almost always fatal if untreated. We’re partnering with the World Health Organization (WHO) to provide AmBisome® free of charge to people in at-risk areas.

Read More

Partnerships aim to address the threat of Ebola

As part of our determination to contain and eliminate public health threats around the world, we’re partnering with public health agencies, NGOs, universities and defense agencies on clinical trials of remdesivir as a treatment for Ebola and other emerging viruses.

Read More

Helping eliminate chronic hepatitis C worldwide

WHO is working to eliminate viral hepatitis worldwide by 2030. Through awareness, screening and care, we’re supporting WHO and helping governments, patients and payers in efforts to eliminate the chronic hepatitis C virus (HCV) and end the disease.

Read More

Keeping girls and young women HIV-free in subSaharan countries

Gilead partners with the U.S. President’s Emergency Plan for AIDS Relief (PEPFAR) to help reduce HIV infections in adolescent girls and young women in 10 sub-Saharan African countries. The DREAMS program has helped cut new diagnoses by up to 40 percent.

Read More

Italy’s first HIV/HCV support center for LGBT population

BLQ Checkpoint in Bologna, Italy – supported by Gilead – is Italy’s first and only community HIV and HCV testing center. It also offers support, counseling, education and a comfortable environment for members of the LGBT community.

Read More